Yongsheng Li Selected Research

Silicon Dioxide (Silica)

1/2020	Fluorescent hybrid silica nanoparticles and their biomedical applications.
1/2020	Strategies To Design and Synthesize Polymer-Based Stimuli-Responsive Drug-Delivery Nanosystems.
4/2019	Facile synthesis of organosilica-capped mesoporous silica nanocarriers with selective redox-triggered drug release properties for safe tumor chemotherapy.
1/2019	Confined growth of multiple gold nanorices in dual-mesoporous silica nanospheres for improved computed tomography imaging and photothermal therapy.
9/2017	Photothermal Ring Integrated Intraocular Lens for High-Efficient Eye Disease Treatment.
2/2017	Silica/organosilica cross-linked block copolymer micelles: a versatile theranostic platform.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yongsheng Li Research Topics

Disease

121	Neoplasms (Cancer) 11/2022 - 08/2010
19	Inflammation (Inflammations) 01/2022 - 11/2007
14	Carcinogenesis 07/2021 - 02/2013
10	Neoplasm Metastasis (Metastasis) 11/2022 - 02/2013
10	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 07/2014
8	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 10/2011
8	COVID-19 04/2021 - 01/2020
6	Hypoxia (Hypoxemia) 01/2021 - 01/2009
6	Glioma (Gliomas) 01/2021 - 12/2013
5	Breast Neoplasms (Breast Cancer) 01/2020 - 10/2014
5	Alzheimer Disease (Alzheimer's Disease) 07/2013 - 08/2003
4	Atherosclerosis 05/2022 - 05/2014
4	Ovarian Neoplasms (Ovarian Cancer) 11/2021 - 10/2019
4	Gallbladder Neoplasms (Gallbladder Cancer) 11/2021 - 10/2020
4	Stomach Neoplasms (Stomach Cancer) 07/2019 - 07/2014
4	Glioblastoma (Glioblastoma Multiforme) 10/2018 - 12/2013
3	Infections 12/2022 - 05/2015
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 09/2019
3	Pain (Aches) 01/2022 - 09/2021
3	Pathologic Processes 01/2021 - 01/2019
3	Parkinson Disease (Parkinson's Disease) 01/2018 - 09/2012
3	Amyloid Plaque 01/2013 - 07/2004
2	Starvation 09/2022 - 01/2022
2	Insulin Resistance 01/2022 - 01/2021
2	Proteinuria 01/2022 - 01/2021
2	Ulcer 01/2022 - 01/2018
2	Rheumatoid Arthritis 01/2022 - 11/2018
2	Fibrosis (Cirrhosis) 01/2022 - 09/2017
2	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2015
2	Osteoarthritis 06/2021 - 06/2020
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2021 - 01/2021
2	Peritonitis 01/2021 - 01/2014
2	Sepsis (Septicemia) 01/2021 - 11/2019
2	Body Weight (Weight, Body) 01/2021 - 07/2019

Drug/Important Bio-Agent (IBA)

21	Biomarkers (Surrogate Marker)IBA 11/2022 - 12/2013
20	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2013
17	MicroRNAs (MicroRNA)IBA 12/2021 - 01/2012
16	Pharmaceutical PreparationsIBA 07/2022 - 02/2010
14	Long Noncoding RNAIBA 05/2022 - 03/2015
10	CytokinesIBA 01/2022 - 11/2007
9	LigandsIBA 12/2021 - 07/2004
8	Biological ProductsIBA 01/2020 - 07/2014
7	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 01/2017
7	LipidsIBA 01/2022 - 08/2010
6	Transcription Factors (Transcription Factor)IBA 12/2022 - 01/2009
6	MicellesIBA 09/2022 - 02/2017
6	EnzymesIBA 01/2021 - 04/2015
6	Contrast MediaIBA 06/2020 - 04/2011
6	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020 - 02/2017
5	Glutathione (Reduced Glutathione)IBA 07/2022 - 04/2019
5	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2022 - 02/2019
5	Peptides (Polypeptides)IBA 05/2022 - 01/2013
5	RNA (Ribonucleic Acid)IBA 05/2022 - 11/2015
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2009
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2020
5	Messenger RNA (mRNA)IBA 11/2021 - 12/2013
5	Competitive Endogenous RNAIBA 01/2021 - 09/2015
4	AntioxidantsIBA 07/2022 - 01/2019
4	RNA-Binding Proteins (RNA-Binding Protein)IBA 12/2021 - 01/2020
4	AntibodiesIBA 10/2021 - 08/2010
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2022
3	Circular RNAIBA 01/2022 - 01/2017
3	Dinoprostone (PGE2)FDA Link 01/2022 - 10/2018
3	C-Reactive ProteinIBA 01/2022 - 05/2014
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 11/2007
3	CalciumIBA 01/2022 - 12/2011
3	InterferonsIBA 12/2021 - 05/2014
3	NF-kappa B (NF-kB)IBA 12/2021 - 12/2008
3	GoldIBA 01/2020 - 08/2017
3	oxidized low density lipoproteinIBA 01/2020 - 05/2014
3	lipoxin A4IBA 04/2014 - 08/2010
3	Amyloid (Amyloid Fibrils)IBA 01/2013 - 07/2004
3	LipoxinsIBA 10/2011 - 01/2009
3	Amyloid beta-PeptidesIBA 09/2004 - 08/2003
2	ProteomeIBA 10/2022 - 01/2020
2	NucleotidesIBA 10/2022 - 01/2017
2	MetalsIBA 10/2022 - 01/2019
2	Glucose OxidaseIBA 09/2022 - 01/2022
2	IonsIBA 07/2022 - 01/2022
2	CopperIBA 07/2022 - 01/2022
2	Indicators and Reagents (Reagents)IBA 05/2022 - 01/2016
2	Liposomes (Liposome)IBA 05/2022 - 01/2020
2	ProcalcitoninIBA 01/2022 - 12/2020
2	NAD (NADH)IBA 01/2022 - 10/2021
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 11/2019
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 02/2021
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2021 - 01/2020
2	InterleukinsIBA 12/2021 - 05/2014
2	VaccinesIBA 12/2021 - 10/2014
2	Antiviral Agents (Antivirals)IBA 03/2021 - 02/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 02/2021 - 01/2020
2	PolymersIBA 01/2021 - 01/2020
2	Metalloproteases (Metalloproteinases)IBA 01/2021 - 11/2019

Therapy/Procedure

47	Therapeutics 09/2022 - 01/2009
15	Drug Therapy (Chemotherapy) 01/2022 - 04/2018
13	Immunotherapy 11/2022 - 07/2014
6	Lasers (Laser) 09/2022 - 12/2011
6	Precision Medicine 05/2022 - 01/2019
3	Photothermal Therapy 01/2022 - 10/2019
3	Critical Care (Surgical Intensive Care) 01/2021 - 01/2020